Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - citalopram as hydrobromide - tablets - citalopram as hydrobromide 20 mg - citalopram - for the treatment of states of depression or panic disorder.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - citalopram as hydrobromide - tablets - citalopram as hydrobromide 40 mg - citalopram - for the treatment of states of depression or panic disorder.

Iżrael - Ingliż - Ministry of Health

truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 17.8 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).

Iżrael - Ingliż - Ministry of Health

truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 4.45 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).

Iżrael - Ingliż - Ministry of Health

abic marketing ltd, israel - pioglitazone as hydrochloride - tablets - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.pioglitazone teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .

Iżrael - Ingliż - Ministry of Health

abic marketing ltd, israel - pioglitazone as hydrochloride - tablets - pioglitazone as hydrochloride 30 mg - pioglitazone - pioglitazone teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.pioglitazone teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .

Iżrael - Ingliż - Ministry of Health

abic marketing ltd, israel - pioglitazone as hydrochloride - tablets - pioglitazone as hydrochloride 45 mg - pioglitazone - pioglitazone teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.pioglitazone teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .

Iżrael - Ingliż - Ministry of Health

teva israel ltd - caffeine anhydrous; chlorpheniramine maleate; paracetamol; phenylephrine hydrochloride - tablets - paracetamol 300 mg; chlorpheniramine maleate 2.0 mg; phenylephrine hydrochloride 10 mg; caffeine anhydrous 30 mg - phenylephrine, combinations - symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain.

Iżrael - Ingliż - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone - foster 200/6 is indicated in the regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - eimeria acervulina hp; eimeria maxima cp; eimeria maxima mfp; eimeria mitis hp; eimeria tenella hp - misc. vaccines or anti sera - eimeria acervulina hp vaccine-general active 500.0 ooc/dose; eimeria maxima cp vaccine-general active 200.0 ooc/dose; eimeria maxima mfp vaccine-general active 100.0 ooc/dose; eimeria mitis hp vaccine-general active 1000.0 ooc/dose; eimeria tenella hp vaccine-general active 500.0 ooc/dose - immunotherapy - poultry broilers (meat for human consum) | chickens | chooks | meat birds - coccidiosis - see label for causes | eimeria acervulina | eimeria arloingi | eimeria bovis | eimeria brunetti | eimeria christenseni | eimeria maxima | eimeria mitis | eimeria mivati | eimeria necatrix | eimeria ninakohlyakimovae | eimeria praecox | eimeria tenella | eimeria zuernii